» Articles » PMID: 33381426

New Insights on Potential Permanent Pacemaker Predictors in TAVR Using the Largest Self-expandable Device

Overview
Date 2020 Dec 31
PMID 33381426
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Post-procedural conduction disorders following transcatheter aortic valve replacement (TAVR) still remain frequent, especially using the largest self-expandable device (Medtronic Corevalve Evolut R, 34 mm, STHV-34). We, therefore, assessed previously described, predictive factors of permanent pacemaker (PPM) implantation in the context of the STHV-34, including calcification distribution, implantation depth and membranous septum length (MSL).

Methods: We performed a dual centre analysis of 130 of 182 consecutive patients treated with STHV-34, further stratified into subjects without post-procedural PPM (-PPM n=100, 76.9%) and those requiring post-procedural PPM (+PPM n=30, 23.1%). These events were further analyzed by univariate and multivariate analysis according to several underlying conditions.

Results: Multivariate analysis only depicted previous right bundle branch block [RBBB; OR: 11.52 (2.63-50.44), P=0.001] and eccentricity index of the left ventricular outflow tract (LVOT-EI) >0.3 [OR: 3.07 (1.22-7.77), P=0.018] as highly predictive for PPM-need, being also confirmed by c-statistics [area under the curve (AUC) =0.68; 95% confidence interval (CI): 0.57-0.80; P=0.0025]. There was only moderate correlation of implantation depth over the MSL in terms of PPM prediction (r=0.23; P<0.0001).

Conclusions: This study offers new insights into potential PPM predictors using the STHV-34: previous RBBB and a pronounced LVOT-EI were independent predictors of PPM, while most of the previously reported determinants failed to predict PPM-need including MSL and implantation depth.

Citing Articles

Factors Influencing Implantation Depth During Transcatheter Aortic Valve Replacement.

Veulemans V, Maier O, Zeus T Interv Cardiol. 2024; 19:e01.

PMID: 38464494 PMC: 10918527. DOI: 10.15420/icr.2023.05.


Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation.

Lauten P, Costello-Boerrigter L, Goebel B, Gonzalez-Lopez D, Schreiber M, Kuntze T J Cardiovasc Dev Dis. 2023; 10(6).

PMID: 37367395 PMC: 10299451. DOI: 10.3390/jcdd10060230.


Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device.

Veulemans V, Wilde N, Wienemann H, Adrichem R, Hokken T, Al-Kassou B Front Cardiovasc Med. 2023; 9:1064916.

PMID: 36684595 PMC: 9849574. DOI: 10.3389/fcvm.2022.1064916.


Factors associated with a high or low implantation of self-expanding devices in TAVR.

Veulemans V, Maier O, Piayda K, Berning K, Binnebossel S, Polzin A Clin Res Cardiol. 2021; 110(12):1930-1938.

PMID: 34165599 PMC: 8639548. DOI: 10.1007/s00392-021-01901-3.

References
1.
Eitan A, Witt J, Stripling J, Haselbach T, Riess F, Schofer J . Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm. Catheter Cardiovasc Interv. 2018; 92(7):1374-1379. DOI: 10.1002/ccd.27588. View

2.
Fujita B, Kutting M, Seiffert M, Scholtz S, Egron S, Prashovikj E . Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 2016; 17(12):1385-1393. DOI: 10.1093/ehjci/jev343. View

3.
Khawaja M, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S . Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011; 123(9):951-60. DOI: 10.1161/CIRCULATIONAHA.109.927152. View

4.
Hellhammer K, Piayda K, Afzal S, Kleinebrecht L, Makosch M, Hennig I . The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R. JACC Cardiovasc Interv. 2018; 11(22):2314-2322. DOI: 10.1016/j.jcin.2018.07.023. View

5.
Jilaihawi H, Chakravarty T, Weiss R, Fontana G, Forrester J, Makkar R . Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv. 2012; 80(1):128-38. DOI: 10.1002/ccd.23368. View